跳至主要内容
临床试验/NCT07787962
NCT07787962尚未招募不适用

Medium-term Follow-up of a Randomised Controlled Study Evaluating Reconstructive Peri-implantitis Treatment

The University of Western Australia1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
40
试验地点
1
主要终点
success

研究概览

简要总结

This study is a medium-term (6-9 years) follow-up of the health of the tissues surrounding the implant which was treated for peri-implantitis (peri-implant infection) in an already completed study with a 12 month follow-up. Patients who were treated in a randomised controlled trial with a 12 month follow-up will be invited to attend for examination of the implant and an x-ray to assess the bone levels at the implant. Participants will be asked to complete a questionnaire about their overall satisfaction following treatment.

详细描述

Follow-up of 40 participants who were already enrolled in a randomised controlled trial comparing access flap with and without guided bone regeneration for the treatment of peri-implantitis. The 12 month outcomes have been published. doi: 10.1111/clr.14116 This study will provide a medium term (6-9 years) follow-up of the participants Participants will be invited to attend an examination.

Full mouth probing Full mouth bleeding and plaque scores Peri-implant probing depth and recession measurements at the treated implant An intraoral radiograph to evaluate marginal bone levels at the treated implant Questionnaire to evaluate satisifaction with the treatment

Participants will receive maintenance care at the treated implant.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • participants from the previous study ID 37382408
  • participants from the previous study who were treated for peri-implantitis either with access flap or access flap and graft material + barrier membrane.

排除标准

  • - individuals who were not enrolled in the previous study ID 37382408

研究组 & 干预措施

participants who have received surgical peri-implantitis treatment

6 -9 year follow-up after treatment of peri-implantitis

干预措施: Medium-term follow-up of peri-implantitis treatment (Other)

结局指标

主要结局

success

时间窗: minimum 6 years

implant present + peri-implant probing depths ≤ 5 mm + absence of bleeding BOP ( 1 spot of bleeding allowed) + suppuration + no additional bone loss

Number of implants with peri-implant health

时间窗: minimum 6 years

implant present + peri-implant probing depths ≤ 5 mm + absence of bleeding BOP ( 1 spot of bleeding allowed) + absence suppuration + no additional bone loss as compared to baseline measures

次要结局

  • bleeding on probing(minimum 6 years)
  • probing depth (mm)(minimum 6 years)
  • suppuration(minimum 6 years)
  • mucosal recession (mm) change from prior to treatment(minimum 6 years)
  • radiographic marginal bone level compared to bone level pre-treatment(minimum 6 years)
  • patient reported outcomes(minimum 6 years)
  • radiographic marginal bone level compared to 12 month marginal bone level(minimum 6 years)
  • peri-implant probing depth (mm)(minimum 6 years)
  • peri-implant bleeding on probing (presence or absence)(minimum 6 years)
  • peri-implant suppuration (presence or absence)(minimum 6 years)
  • peri-implant mucosal recession (mm)(minimum 6 years)
  • radiographic marginal bone level (mm) compared to bone level at baseline(minimum 6 years)
  • patient reported outcomes on VAS scale 0 - 100 mm(minimum 6 years)
  • radiographic marginal bone level ( mm) compared to 12 month marginal bone level(minimum 6 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lisa Heitz-Mayfield

Adjunct Professor

The University of Western Australia

研究点 (1)

Loading locations...

相似试验